C3 anticorps (PE)
Aperçu rapide pour C3 anticorps (PE) (ABIN1431131)
Antigène
Voir toutes C3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- purified by Protein A
-
Immunogène
- KLH conjugated synthetic peptide derived from human Complement C3 C3a anaphylatoxin
-
Isotype
- IgG
-
-
-
-
Commentaires
-
Excitation / Emission wavelength: 496nm / 578nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 µg/µL
-
Buffer
- Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4 °C for 12 months
-
Date de péremption
- 12 months
-
-
- C3 (Complement Component 3 (C3))
-
Autre désignation
- Complement C3
-
Sujet
- The complement factor C3 consists of an alpha and a beta chain. C3 is a central factor in the complement cascade. It is central to the alternative pathway that leads to the C3 convertase C3bBb. The classical mannose binding lectin activation pathway leads to the C3 convertase C4b2a. These convertases cleave C3 resulting in C3a and C3b. Further degradation leads to the formation of the alpha chain products C3d, C3g and C3c. C3 is an acute phase protein that is produced by a wide range of tissues, including renal epithelial cells and hepatocytes.
-
Poids moléculaire
- 187kDa
-
Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-